Name | Burgess Health Center |
---|---|
Type | Critical Access Hospital |
Location | 1600 Diamond Street, Onawa, Iowa |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 161359 |
NPI Number | 1598924623 |
Organization Name | BURGESS HEALTH CENTER |
Doing Business As | BHC AMBULANCE |
Address | 1600 Diamond St, Onawa, IA 51040 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 712-423-2311 |
News Archive
Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.
At Bayshore Community Hospital, making patients and guests feel at home while they're away from home for a hospital stay is top of mind. While clinical care remains the Hospital's top priority, it is now enhancing the total hospital experience of patients with a new service called Concierge Care. Concierge Care was formed to consistently address personal or "non-clinical needs," making patients and their guests as comfortable as possible.
This post in the Foreign Policy Association blog discusses reports from earlier this month of "an emerging strain of 'totally drug-resistant' tuberculosis (TDR-TB)" in India, which the Indian government last week denied, "arguing that the 12 cases were in fact extensively drug resistant (XDR)."
The U.S. Food and Drug Administration today approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. Natrelle 410 implants are manufactured by Allergan, Inc.
› Verified 3 days ago
NPI Number | 1730253360 |
Organization Name | BURGESS HEALTH CENTER |
Address | 1600 Diamond St, Onawa, IA 51040 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 712-423-2311 |
News Archive
Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.
At Bayshore Community Hospital, making patients and guests feel at home while they're away from home for a hospital stay is top of mind. While clinical care remains the Hospital's top priority, it is now enhancing the total hospital experience of patients with a new service called Concierge Care. Concierge Care was formed to consistently address personal or "non-clinical needs," making patients and their guests as comfortable as possible.
This post in the Foreign Policy Association blog discusses reports from earlier this month of "an emerging strain of 'totally drug-resistant' tuberculosis (TDR-TB)" in India, which the Indian government last week denied, "arguing that the 12 cases were in fact extensively drug resistant (XDR)."
The U.S. Food and Drug Administration today approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. Natrelle 410 implants are manufactured by Allergan, Inc.
› Verified 3 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.
At Bayshore Community Hospital, making patients and guests feel at home while they're away from home for a hospital stay is top of mind. While clinical care remains the Hospital's top priority, it is now enhancing the total hospital experience of patients with a new service called Concierge Care. Concierge Care was formed to consistently address personal or "non-clinical needs," making patients and their guests as comfortable as possible.
This post in the Foreign Policy Association blog discusses reports from earlier this month of "an emerging strain of 'totally drug-resistant' tuberculosis (TDR-TB)" in India, which the Indian government last week denied, "arguing that the 12 cases were in fact extensively drug resistant (XDR)."
The U.S. Food and Drug Administration today approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. Natrelle 410 implants are manufactured by Allergan, Inc.
› Verified 3 days ago
Burgess Health Center Critical Access Hospital Location: 1600 Diamond Street, Onawa, Iowa 51040 Phone: (712) 423-2311 |